File:5tdi cathepsinK odanacatib.png
5tdi_cathepsinK_odanacatib.png (800 × 600 pixels, file size: 266 KB, MIME type: image/png)
Captions
Captions
Summary
[edit]
| Description |
The X-ray crystallography structure of human cathepsin K in complex with the covalent inhibitor odanacatib, shown in light blue with covalently modified catalytic cysteine in green. Odanacatib was studied in clinical trials as a cathepsin K inhibitor for osteoporosis. Rendered with PyMol from PDB: 5TDI. Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib. Law, S., Andrault, P.M., Aguda, A.H., Nguyen, N.T., Kruglyak, N., Brayer, G.D., Bromme, D. (2017) Biochem J 474: 851-864 PubMed: 28049758 DOI: 10.1042/BCJ20160985 |
| Date | 27 Deecember 2021 |
| Source | Own work |
| Author | Opabinia regalis |
Licensing
[edit]
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
|
Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation; with no Invariant Sections, no Front-Cover Texts, and no Back-Cover Texts. A copy of the license is included in the section entitled GNU Free Documentation License. |
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 06:35, 28 December 2021 | | 800 × 600 (266 KB) | Opabinia regalis (talk | contribs) | {{Information |Description=The X-ray crystallography structure of human cathepsin K in complex with the covalent inhibitor odanacatib, shown in light blue with covalently modified catalytic cysteine in green. Odanacatib was studied in clinical trials as a cathepsin K inhibitor for osteoporosis. Rendered with PyMol from {{PDB|5TDI}}. Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib. Law, S., Andrault, P.M., Aguda, A.H., Nguyen, N.T., Kruglyak, N.... |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.
File usage on other wikis
The following other wikis use this file:
- Usage on en.wikipedia.org
